Eastman Chemical Co Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $8.9B-5.5% YoYTTM through 30 Jun 2026
Net Income $442M-51.2% YoYTTM through 30 Jun 2026
Free Cash Flow $539MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 21.1% |
| EBITDA Margin | 12.0% |
| Operating Margin | 8.9% |
| Net Margin | 5.0% |
Returns
8.0%ROE
3.2%ROA
5.6%ROIC
Balance Sheet Health
Debt / Equity0.79x
Current Ratio1.37x
Net Debt$4.2B
Cash & Equivalents$566M
Quality Metrics
Altman Z-Score2.22
Piotroski F-Score6 / 9
FCF Margin6.1%
Rule of 4010.6
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $8.8B
Diluted EPS$3.84TTMFY2025: $4.10
Dividend
$1.68Per share, FY20262.50%Yield-9.9%5-yr growth
Capital Allocation
R&D Spend$246M
Capex Intensity5.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Advanced Materials | $2.9B | -5.6% | View detailsExpects tailwinds from improved sales volume/mix in Advanced Materials in 2026. |
| Additives & Functional Products | $2.9B | +0.6% | View detailsExpects modest volume/mix improvement in 2026. |
| Chemical Intermediates | $1.9B | -9.8% | View detailsTightening market conditions from Middle East conflict are quickly and substantially improving margins in 2026. |
| Fibers | $1.1B | -20.3% | View detailsExpects continued customer inventory destocking and Middle East conflict impacts to affect shipments in early 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.